Delivery Order SPE2DB22D1106-SPE2DB25FEVC8
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 MG/ML Oral Suspension 340ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $4,333.54. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of May 1, 2025 and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,096.77, is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,506.91, is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 mg/ml oral suspension (340 ml), a medication used for the treatment of epilepsy. The contract has a firm fixed price ceiling value of $2,930.70 and a period of performance through June 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FYCOMPA 0.5 mg/mL oral suspension in 340 mL bottles. The contract has a firm fixed price of $1,660.60 and an ultimate completion date of August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FYCOMPA 0.5 mg/ml oral suspension in 340 ml quantities, with a ceiling value of $3,194.49. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,935.66, is for the delivery of FYCOMPA 0.5 mg/ml oral suspension (340 ml). The contract is a Firm Fixed Price Delivery Order with a completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract is a Delivery Order with a Firm Fixed Price of $2,903.46 and an Ultimate Completion Date of January 29, 2025. The contract is not designated as a Set-Aside. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 12 MG TABLET 30S. The contract has a period of performance through September 18, 2024 and a ceiling value of $5,158.92. This contract is not set-aside and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, with a ceiling value of $3,144.10 and a completion date of June 30, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The DLA is the funding agency, and...